Comparing two dyes for lymph node mapping in vulvar cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study compares two methods for finding the first lymph node (sentinel node) that may contain cancer in people with vulvar cancer. It uses a dye called indocyanine green alone or with a radioactive tracer (technetium) to see which approach works better for staging the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman aged 18 or older
- You have vulvar squamous cell carcinoma (or vulvar melanoma) at stage IB (more than 1 mm deep) or small stage II (tumor less than 4 cm)
- Your groin area must appear cancer-free on exam or imaging
- You cannot have had radiation to your pelvis, vulva, or groin before
- You cannot be allergic to technetium or indocyanine green
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new optical method using a dye to find and remove the first lymph node (sentinel node) that cancer might spread to, to stage vulvar cancer more accurately. It's for patients with a smaller tumor (under 4 cm) that hasn't been treated in the groin area before.
This study tests whether a special dye called indocyanine green (ICG) can help find sentinel lymph nodes during breast cancer surgery after chemotherapy. It may offer a safer and more effective way to check if cancer has spread.
This trial tests a dye called ICG to find the first lymph nodes that might have cancer cells. It is for women with early-stage vulvar cancer that has not spread to the lymph nodes.
This trial tests a new way to find and remove the first lymph node that might contain cancer cells in women with large or recurrent vulvar cancer. It uses a special dye to guide the surgeon, which may help improve staging and reduce side effects.
This trial tests if an injection of indocyanine green dye can help surgeons find and remove only the key lymph nodes in the armpit during breast cancer surgery. It aims to reduce the need for more extensive lymph node removal.
This trial looks at how the dose and storage of a dye called indocyanine green (ICG) affects its ability to find sentinel lymph nodes during surgery for gynecologic cancers like cervical, endometrial, and vulvar cancer. The goal is to make the procedure both more effective and more affordable.
Hear when a new Vulvar Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.